Our mission is opening a digital front door to a new kind of healthcare system, one that provides greater access to high quality, convenient and affordable care. No matter who a person is, where they come from, what they look like, or if they have insurance or not—Hims & Hers connects consumers with licensed medical professionals and enables everyone to seek health and wellness care.

HIMS

Andrew Dudum

Chief Executive Officer

Melissa Baird

Chief Operating Officer

Soleil Boughton

Chief Legal Officer and Corporate Secretary

Yemi Okupe

Chief Financial Officer

Chief Executive Officer And Board Of Director

Alex Bard

Board Of Director

Dr. Toby Cosgrove

M.D. Board Of Director

Kirsten Green

Jules Maltz

David Wells

Lynne Chou O’keefe

Andrea Perez

Ambar Bhattacharyya

Dr. Patrick Carroll

About HIMS

Hims & Hers Health (NYSE:HIMS) Stock, Quote.Headers.trade-ideas

Hims & Hers Health

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Brinker

Equities

Mid Cap

News

Movers

Trading Ideas

AKRO

Brighthouse Financial, Inc. - Common Stock

Hims & Hers Health, Inc. Class A Common Stock

SGRY

VIAV

Check out this week&#39;s top-performing mid-cap stocks, including Akero Therapeutics&#39; remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.

Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?

GEHC


The advent of GLP-1 treatments has been a game changer in the medical sector for weight loss and chronic obesity. The GLP-1 market is currently dominated by semaglutide (Ozempic and Wegovy) produced by Novo Nordisk

Ultrasound Weight Loss: GE HealthCare and Novo Nordisk&#39;s Play

Hims & Hers Health Inc

Natural Health Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NHTC#NASDAQ">NHTC</a>) reported quarterly earnings of $0.02 per share. This is a 33.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported $10.85 million in sales this quarter. This is a 0.83 percent decrease over sales of $10.94 million the same period last year.

Earnings

NHTC

Natural Health Trends Q4 EPS $0.02 Down From $0.03 YoY, Sales $10.85M Down From $10.94M YoY

Stanley Black &amp; Decker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) shares are trading lower after the company reported better-than-expected <a href="https://www.benzinga.com/pressreleases/25/02/n43489206/stanley-black-decker-reports-4q-full-year-2024-results">fourth-quarter results and provided 2025 guidance.</a>
Stanley Black&nbsp;&amp; Decker&nbsp;reported a fourth-quarter sales decline of 0.43% year over year to $3.720 billion, beating the consensus estimate of $3.580 billion.
Quarterly net sales remained flat, as volume growth (+4%) was offset by declines in price (-1%), currency (-1%), and the Infrastructure divestiture (-2%).
Gross profit increased 3.6% to $1.144 billion, and the gross margin expanded by 120 basis points to 30.8%. The adjusted gross margin was 31.2%, up 140 bps YoY.
Net earnings from continuing operations were 5.2% of sales, up from a loss from continuing operations (7.4%) of sales in the prior year. EBITDA rose to 9.1% of sales from 4.2%, while adjusted EBITDA increased to 10.2% of sales from 9.4%.
Adjusted EPS of $1.49 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus of $1.27.</a>
Tools &amp; Outdoor net sales grew 2% YoY, with 4% volume growth offset by price (-1%) and currency (-1%), driving 3% organic revenue growth. Tools &amp; Outdoor segment margin was 9.2%, down 10 bps YoY, and adjusted segment&nbsp;margin rose to 10.2% (+20 bps), supported by supply chain transformation despite higher costs and growth investments.
Industrial net sales declined 15% YoY, with flat organic sales. Industrial&nbsp;segment margin dropped to 10.7% from 11.2% and an adjusted margin was 10.7% vs. 11.1%, primarily due to lower automotive volume.
Operating cash flow for the quarter was $679 million, compared to $769.3 million a year ago. Free cash flow was ~$565 million. Stanley held $290.5 million in cash and equivalents as of December 28, 2024.
In the fourth quarter, Stanley Black &amp; Decker&#8217;s Global Cost Reduction Program generated $110 million in additional pre-tax savings, contributing to total savings of approximately $1.5 billion since mid-2022 and supporting a return to 35%+ adjusted gross margins.
&#8220;With the recent tariff announcements, we are preparing for a dynamic backdrop in 2025 and expect to respond with supply chain and price actions designed to mitigate the impact from such tariffs to maintain our margin objectives, which enable us to fuel innovation and brand building. Our top priorities remain delivering margin expansion, cash generation and restoring balance sheet strength over the next 12 to 18 months to position the company for long-term growth and value creation,&#8221; commented Patrick D. Hallinan, Executive Vice President and CFO.
2025 Outlook: Excluding new tariffs, Stanley Black &amp; Decker expects GAAP EPS of $4.05 (+/- $0.65) and <a href="https://www.benzinga.com/calendars/guidance">adjusted EPS of $5.25 (+/- $0.50) versus consensus of $5.38.</a>
The GAAP-to-adjusted EPS difference of $1.05 to $1.35 mainly reflects charges from the Global Cost Reduction Program&#8217;s supply chain transformation.
The company sees free cash flow of $750 million (+/—$100 million), excluding new tariffs.
The company plans to provide its base planning assumptions and commentary on the current tariff environment. In its conference call, the company said it sees annualized, unmitigated hit of around $90 million &#8211; $100 million if 10% China tariffs remain.
Price Action: SWK shares are trading lower by 5.67% at $81.75 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/43493607" target="_blank" rel="noreferrer noopener">Chinese Stocks Slide As Trump Eyes More Tariffs And Tougher Trade Restrictions</a></li>
</ul>
Image via Shutterstock.

Guidance

Tool Company Stanley Black & Decker's Q4 Earnings Win Overshadowed by Tariff Trouble - What's Going On?

Walt Disney Co&nbsp;(NYSE:&nbsp;DIS)&nbsp;reported fiscal first-quarter&nbsp;2025 revenue growth of 5% year-on-year to $24.70 billion, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43489835/the-walt-disney-company-reports-first-quarter-earnings-for-fiscal-2025" rel="noreferrer noopener">analyst consensus of $24.62 billion</a>. Adjusted EPS of $1.76 beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus of $1.45</a>.
Disney ended the quarter with 178 million Disney+ Core and Hulu subscriptions and 125 million Disney+ Core paid subscribers, a decrease of 0.7 million over the prior quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/02/43458397/sam-altman-in-korea-openai-seeks-ai-deals-with-samsung-sk-hynix-and-softbank-amid-global-ai-boom" rel="noreferrer noopener">Sam Altman in Korea: OpenAI Seeks AI Deals With Samsung, SK Hynix, and SoftBank Amid Global AI Boom</a>
Segments: Entertainment revenue (which encompasses traditional TV networks,&nbsp;direct-to-consumer streaming, and films) increased by 9% year over year to $10.87 billion.
Sports revenue (mostly comprised of ESPN) remained flat year over year at $4.85 billion. Experiences revenue (including Disney&#8217;s theme parks and consumer products) climbed 3% year over year to $9.42 billion.
In the Entertainment segment, Linear Networks revenue declined by 7% year over year to $2.62 billion, Direct-to-Consumer revenue climbed 9% year over year to $6.07 billion, and Content Sales/Licensing and Other revenue grew by 34% year over year to $2.18 billion.
The combined DTC streaming businesses improved their profitability with an operating income of $293 million on revenue of $6.07 billion (up by 9% year over year).
Moana 2 and Mufasa: The Lion King&nbsp;helped drive $312 million in operating income at Content Sales/Licensing and Other in the quarter.
The average revenue per user for domestic Disney+ customers increased from $7.20 during the September 28 quarter to $7.55 due to a higher mix of customers on its cheaper, ad-supported tier.&nbsp;
The consolidated operating income grew 31% year over year to $5.06 billion, led by the Entertainment segment&#8217;s $1.70 billion, the Sports segment&#8217;s $247 million, and the Experiences segment&#8217;s $3.11 billion.
Disney generated a quarterly operating cash flow of $3.21 billion (up 47% year over year) and a free cash flow of $739 million (down 17% year over year).
CEO Robert A. Iger flagged outstanding box office performance from its studios, which had the top three movies of 2024, profitability boost of its Entertainment DTC streaming businesses, and the addition of ESPN tile on Disney+.
Outlook:&nbsp;For fiscal 2025, Disney reiterated <a target="_blank" href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance" rel="noreferrer noopener">high-single-digit</a> growth in adjusted earnings per share (EPS) compared to 2024 versus a <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus of $5.41</a>.
The company aims to generate around $15 billion in operating cash flow.
It expects double-digit growth in operating income for the Entertainment segment in fiscal 2025, with an increase in DTC operating income of around $875 million.
Disney expects its Experience segment to see operating income growth of 6%-8% in fiscal 2025.
The company expects its Sports segment to grow 13% in fiscal 2025.
Price Actions: DIS stock is down 0.88% at $112.30 premarket at&nbsp;the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/43444802/comcast-downgraded-as-broadband-struggles-and-price-cuts-raise-investor-concerns" target="_blank" rel="noreferrer noopener">Comcast Faces Broadband Headwinds, Analyst Downgrades Stock And Cuts Price Forecast</a></li>
</ul>
Photo bychingyunsong via Shutterstock

Tech

Disney Q1 Earnings: Revenue And EPS Beat, Moana 2 and Mufasa Power Operating Income, 700K Drop In Streaming Subscribers

WIIM

ATEN

A10 Networks shares are trading lower. The company reported Q4 financial results.

Embraer-Empresa Brasileira De Aeronautica

Embraer shares are trading higher after its executive jets subsidiary announced a purchase agreement with Flexjet in which it secured a $7 billion order.

Geoffrey Kendrick, Head of Digital Assets Research at Standard Chartered on Wednesday predicted that Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) could reach $500,000 before the <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43492011/exclusive-crypto-czar-charm-offensive-welcomed-but-experts-wonder-will-us-policy-deliver">end of Donald Trump's term</a>.
What Happened: Kendrick attributes this forecast to two key factors: improved investor access to Bitcoin under the current administration and a gradual decline in volatility due to maturing market infrastructure.
"Access is improving under the Trump administration. Institutional inflows will continue to gather pace," Kendrick wrote, highlighting the impact of spot Bitcoin ETFs and expanding options markets. 
"This combination—more access, lower vol—is enough to drive Bitcoin to $500,000 before Trump leaves office,&#8221; he added.
Meanwhile, institutional inflows into <a href="https://www.benzinga.com/etfs/specialty-etfs/25/01/43249653/nasdaqs-bitcoin-etf-shift-could-strengthen-blackrocks-market-position">Bitcoin and Ethereum ETFs</a> further underline the growing adoption of digital assets.
On Feb. 4, Bitcoin spot ETFs recorded a net inflow of $341 million, with BlackRock's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) ETF alone receiving $249 million.
Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) ETFs saw a net inflow of $308 million, marking the fourth consecutive day of positive flows for the asset.
These numbers highlight increasing confidence among institutional investors, despite recent market turbulence. 
Kendrick said that improved access through vehicles like ETFs is critical for Bitcoin's long-term trajectory, as it provides broader exposure for traditional finance participants.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43475386/exclusive-anthony-scaramucci-warns-donald-trumps-crypto-promises-may-be-a-mirage">EXCLUSIVE: Anthony Scaramucci Warns Donald Trump&#8217;s Crypto Promises May Be A &#8216;Mirage&#8217;</a>
Why It Matters: Recent volatility in traditional and crypto markets has tested investor sentiment.
The U.S.-China tariff war continues to dominate headlines, creating uncertainty across asset classes. While Bitcoin has shown resilience, holding above the $90,000 mark, concerns about geopolitical shocks remain.
"The delay in tariffs against Mexico and Canada has provided some relief to crypto markets," QCP Capital noted but cautioned that Bitcoin is still vulnerable to negative price shocks given the lack of near-term catalysts. 
The firm also highlighted the ongoing development of regulatory frameworks, such as stablecoin legislation and a Strategic <a href="https://in.benzinga.com/markets/cryptocurrency/25/02/43489967/the-trump-bitcoin-reserve-ushers-in-golden-age#:~:text=The%20Bitcoin%20Reserve%20Act%20requires,the%20course%20of%20criminal%20investigations.">Bitcoin Reserve</a> (SBR) task force, as long-term <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43477333/crypto-czar-sacks-says-potential-bitcoin-reserve-to-be-one-of-crypto-committees-first-priorities\">positives for the crypto industry.</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43473182/could-the-trump-established-sovereign-wealth-fund-invest-in-bitcoin-nvidia-tiktok">Could The Trump-Established Sovereign Wealth Fund Invest In Bitcoin, Nvidia, TikTok?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

IBIT

Bitcoin To Reach $500,000 Before Trump Leaves Office: Standard Chartered

Disney CEO Iger Says A New Sportscenter Daily Show Coming to Disney+ Is Intended To Drive Engagement

TNXP

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

JPMorgan analysts Claudia Hueston and Pedro Martins just dropped a major AI ripple effect report, and the verdict is clear: DeepSeek's latest LLM is shaking up <a href="https://www.benzinga.com/topic/artificial-intelligence">the tech hierarchy</a>.
With the promise of slashing training and inference costs, some companies stand to gain big, while others might be in for a rough ride.
<h2 class="wp-block-heading">Winners: The AI Powerhouses</h2>
The bullish camp — tagged under JPMorgan's DeepSeek Positive Impact — is a who's who of AI titans and cloud leaders. Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) top the list, unsurprisingly, given their AI ambitions.
But the wave also lifts Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) and Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) — all crucial to AI infrastructure. Even software players like Snowflake Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), Databricks rival Confluent Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) and GitLab Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) look poised to benefit from AI-powered cost efficiencies.
The key theme? AI is moving from experimental to execution mode, and companies that enable inferencing and data management stand to gain.
Read Also: <a href="https://www.benzinga.com/25/02/43487551/sundar-pichai-acknowledges-deepseeks-ai-advancementsbut-says-googles-gemini-still-leads-in-cost-performance-and-latency">Sundar Pichai Downplays DeepSeek Threat — Google&#8217;s Gemini Still Leads In Cost, Performance, And Latency</a>
<h2 class="wp-block-heading">Losers: The Hardware Setback</h2>
On the flip side, JPMorgan's DeepSeek Negative Impact list puts companies like Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) and Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) in the danger zone. With cheaper and more efficient AI models, legacy hardware players could see slower demand for expensive, high-power training chips. 
Even industrial giants like Caterpillar Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) and Cummins Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) might take a hit if AI-driven automation undercuts traditional heavy machinery investments.
<h2 class="wp-block-heading">The Takeaway: AI's Next Economic Shift</h2>
While hyperscalers are still throwing money at AI hardware, DeepSeek's disruption could eventually tilt the value proposition toward application-layer innovation. 
Companies that enable seamless AI adoption—think Salesforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>), Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) and CrowdStrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>)—could see an acceleration in demand, while those overly reliant on expensive, legacy infrastructure may need a strategy refresh.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/25/02/43487668/amd-ceo-lisa-su-on-deepseeks-ai-disruption-training-and-inference-with-less-infrastructure-is-a-good-thingbut-gpus-not-asics-will-still-power-the-future-of-ai-chips">AMD CEO Lisa Su On DeepSeek&#8217;s AI Disruption: &#8216;Training And Inference With Less Infrastructure Is A Good Thing&#8217; — But GPUs, Not ASICs, Will Still Power The Future Of AI Chips</a></li>
</ul>
Image: Shutterstock

Analyst Color

Long Ideas

Analyst Ratings

AMZN

AVGO

CFLT

CRWD

GOOG

GOOGL

GTLB

INTC

MRVL

NVDA

ORCL

SHOP

SNOW

JPMorgan Picks Winners, Losers After DeepSeek Debut: How Alphabet, Amazon, Intel And Oracle Rank

Barclays analyst Alex Scott maintains Voya Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYA#NYSE">VOYA</a>) with a Overweight and lowers the price target from $79 to $75.

Price Target

VOYA

Barclays Maintains Overweight on Voya Financial, Lowers Price Target to $75

Dayforce shares are trading lower. The company reported Q4 financial results.

SKYQ

RB Residential And Sky Quarry Combine Forces Sign LOI To Integrate Advanced Sustainability Tech With Expert Roofing Services

Barclays analyst Kannan Venkateshwar maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Overweight and raises the price target from $475 to $710.

SPOT

Barclays Maintains Overweight on Spotify Technology, Raises Price Target to $710

Electronic Arts shares are trading higher after the company reported better-than-expected Q3 EPS results. B of A Securities raised its price target on the stock from $130 to $132.

Benchmark analyst Cody Acree maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Buy and lowers the price target from $200 to $170.

Benchmark Maintains Buy on Advanced Micro Devices, Lowers Price Target to $170

Private employers created 183,000 new jobs in January 2025, marking a slight acceleration from December&#8217;s upwardly revised 176,000 and beating market <a href="https://www.benzinga.com/news/econ-s">expectations of 150,000. </a>
The ADP National Employment Report, released Wednesday by Automatic Data Processing Inc., highlighted continued resilience in the private labor market ahead of Friday's highly anticipated non-farm payrolls report from the Bureau of Labor Statistics. Economists expect the government report to show a slowdown in hiring, with forecasts predicting a decline from December's 256,000 to 170,000 new jobs.
Nela Richardson, ADP&#8217;s chief economist, said: &#8220;We had a strong start to 2025 but it masked a dichotomy in the labor market. Consumer-facing industries drove hiring, while job growth was weaker in business services and production.&#8221;
<h3 class="wp-block-heading">Where Did Jobs Grow in January?</h3>
The latest data revealed a divergence in job creation, with gains concentrated in service-providing industries, while goods-producing sectors continued to lag.
Goods-producing industries shed 6,000 jobs in January, driven by a 13,000 payroll reduction in manufacturing. This marked the fourth consecutive month of job losses in the sector.
Service-providing industries, on the other hand, added 190,000 positions. Trade, transportation, and utilities led the way with 56,000 new jobs, while leisure and hospitality followed closely, adding 54,000 positions.
December&#8217;s private employment growth was also revised upward to 184,000, exceeding the consensus estimate of 150,000 tracked by TradingEconomics.
The ADP report signaled ongoing moderation in wage growth. Pay increases for job stayers in January edged up 4.7% year-over-year, while job changers saw salary gains of 6.8%, down from 7.1% in December.
These figures suggest that while the labor market remains strong, wage pressures are easing—a key factor for the Federal Reserve as it assesses the timing of potential interest rate cuts in 2025.
<h3 class="wp-block-heading">Market Reactions</h3>
The U.S. Dollar Index (DXY) – as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – inched slightly higher minutes after the release, trimming losses for the day. 
Futures on major U.S. indices edged lower during premarket trading in New York. The SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was 0.4% lower by 8:25 a.m. ET. 
Shares of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) were 2.4% and 7.2% lower, respectively, weighing on tech-heavy indices. 
Gold – tracked by SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) – continued to extend record highs, with the bullion rising to $2,870 per ounce, approaching double-digit gains year-to-date. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43489453/us-stocks-likely-to-open-lower-following-alphabet-amd-earnings-walt-disney-uber-ford-qualcomm-in-focus">US Stocks Likely To Open Lower Following Alphabet, AMD Earnings: Walt Disney, Uber, Ford, Qualcomm In Focus</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Broad U.S. Equity ETFs

Specialty ETFs

Currency ETFs

Forex

Econ #s

Economics

Federal Reserve

ETFs

AAPL

PowerShares DB US Dollar Index Bullish Fund

Private Employment Rises By 183,000, Beats Estimates In January: 'Consumer-Facing Industries Drove Hiring'

Atlassian's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NYSE">TEAM</a>) short percent of float has risen 7.72% since its last report. The company recently reported that it has 4.49 million shares sold short, which is 2.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.45 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Atlassian Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738763250_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Atlassian has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Atlassian's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Atlassian's peer group average for short interest as a percentage of float is 3.02%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

TEAM

(TEAM) - Analyzing Atlassian's Short Interest

American Water Works's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) short percent of float has risen 9.62% since its last report. The company recently reported that it has 4.86 million shares sold short, which is 2.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>American Water Works Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738763245_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for American Water Works has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing American Water Works's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, American Water Works's peer group average for short interest as a percentage of float is 3.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into American Water Works's Recent Short Interest

Mobileye Global's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NYSE">MBLY</a>) short percent of float has risen 17.37% since its last report. The company recently reported that it has 21.44 million shares sold short, which is 29.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.1 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Mobileye Global Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738763240_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Mobileye Global has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Mobileye Global's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Mobileye Global's peer group average for short interest as a percentage of float is 5.80%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MBLY

Looking Into Mobileye Global's Recent Short Interest

On Wednesday,&nbsp;Boston Scientific Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>)&nbsp;reported fourth-quarter revenues of $4.56 billion, beating the&nbsp;consensus&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">estimate of $4.424 billion</a>.
Sales increased 22.4% on a reported basis, compared to the company&#8217;s guidance range of 16.5%-18.5%, and 23.1% on an operational basis, 19.5% on an organic basis, compared to the company&#8217;s&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41490484/boston-scientific-q3-earnings-revenue-and-eps-beat-lifts-annual-forecast-on-strong-demand-for-heart" rel="noreferrer noopener">guidance range of 14%-16%</a>.
The company earned an adjusted EPS of 70 cents, beating the consensus of 66 cents and the management&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43489813/boston-scientific-announces-results-for-fourth-quarter-and-full-year-2024" rel="noreferrer noopener">guidance of $0.64-$0.66</a>.
&#8220;2024 was one of the best years in the history of Boston Scientific, fueled by our innovative portfolio, the launch of our FARAPULSE Pulsed Field Ablation System, as well as significant clinical achievements and commercial excellence across businesses and regions,&#8221; said Mike Mahoney, chairman and chief executive officer of Boston Scientific.
The company&#8217;s cardiovascular segment generated sales of $2.94 billion, rising 28.8% (29.5% operationally and 27.4% organically).
<ul>
<li>Boston Scientific reported 31.1% growth in cardiology products and 21% in peripheral interventions.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/42881585/boston-scientific-expands-cardiovascular-treatment-portfolio-with-440-million-bolt-medical-deal" rel="noreferrer noopener">Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal</a>
MedSurg segment revenues increased 12.4% to $1.62 billion (13% operationally and 7% organically).
<ul>
<li>Urology led the way with a 19.5% increase. Neuromodulation (+11.4%) and Endoscopy (7%) followed.</li>
</ul>
Outlook: Boston Scientific forecasts net sales growth of approximately 12.5%-14.5% in 2025 on a reported basis and approximately 10%-12% on an organic basis.
The company estimates 2025 adjusted EPS $2.80-$2.87 compared to consensus of $2.81.
The company estimates net sales growth for the first quarter of 2025 of approximately 17%-19% on a reported basis and approximately 14%-16% on an organic basis, with adjusted EPS of $0.66-$0.68 compared to consensus of $0.64.
Price Action:&nbsp;BSX stock is up 0.84% at $104.41 during the premarket session at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43474141/tyson-foods-stock-trading-around-fair-value-analyst-upgrades-stock-to-neutral" target="_blank" rel="noreferrer noopener">Tyson Foods Stock Trading Around Fair Value, Analyst Upgrades Stock To Neutral</a></li>
</ul>

Large Cap

Health Care

General

Boston Scientific Clocks 22% Jump In Q4 Sales On Strong Heart Devices, Profit And Guidance Exceeds Expectations

Press Releases

Define Ventures Appoints Bruce Broussard as Venture Partner

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys

Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category

The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight

Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

Hims & Hers Launches Health Collective and Community Member Council

Citigroup

BTIG

Piper Sandler

Needham

Morgan Stanley

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

MGRX

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Screenshot 2024-07-09 at 1.59.17 PM

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Comments

Hims & Hers Health

Hims & Hers Health (HIMS) Forecast

Hims & Hers Health (NYSE:HIMS) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga